A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

NCT01377922 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Lambert Eaton Myasthenic Syndrome

Interventions

DRUG: Amifampridine Phosphate
DRUG: Placebo

Sponsor

Catalyst Pharmaceuticals, Inc.